{
     "PMID": "27118677",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170214",
     "LR": "20170214",
     "IS": "1532-2785 (Electronic) 0143-4179 (Linking)",
     "VI": "59",
     "DP": "2016 Oct",
     "TI": "Antioxidative stress effect of epicatechin and catechin induced by Abeta25-35 in rats and use of the electrostatic potential and the Fukui function as a tool to elucidate specific sites of interaction.",
     "PG": "89-95",
     "LID": "S0143-4179(16)30038-5 [pii] 10.1016/j.npep.2016.04.001 [doi]",
     "AB": "Alzheimer's disease (AD) is a neurodegenerative disorder caused by the aggregation of the amyloid-beta peptide (Abeta) in senile plaques and cerebral vasculature. The Abeta25-35 fraction has shown the most toxicity; its neurotoxic mechanisms are associated with the generation of oxidative stress and reactive astrogliosis that induce neuronal death and memory impairment. Studies indicate that pharmacological treatment with flavonoids reduces the rate of AD, in particular, it has been shown that antioxidants are compounds that could interact with this peptide due to their antioxidant proprieties. In this study, experimental and computational tools were used to calculate the molecular electrostatic potential and the Fukui function with the Gaussian 09 computational program, to predict the most reactive parts of these molecules and make the complex between Abeta25-35 and two flavonoids (catechin and epicatechin) in the absolute gas-phase, where a possible interaction between them was observed. This is important for understanding the Abeta25-35-Flavonoid (A-F) interaction as a therapeutic strategy to inhibit the neurotoxic effects that this peptide causes in AD, which currently is still considered an ambiguous process.",
     "CI": [
          "Copyright (c) 2016 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Cruz-Gonzalez, Trinidad",
          "Cortez-Torres, Estephania",
          "Perez-Severiano, Francisca",
          "Espinosa, Blanca",
          "Guevara, Jorge",
          "Perez-Benitez, Aaron",
          "Melendez, Francisco J",
          "Diaz, Alfonso",
          "Ramirez, Ramses E"
     ],
     "AU": [
          "Cruz-Gonzalez T",
          "Cortez-Torres E",
          "Perez-Severiano F",
          "Espinosa B",
          "Guevara J",
          "Perez-Benitez A",
          "Melendez FJ",
          "Diaz A",
          "Ramirez RE"
     ],
     "AD": "Departamento de Fisicomatematicas, Facultad de Ciencias Quimicas Benemerita Universidad Autonoma de Puebla, Av. San Claudio y 14 Sur, Col. San Manuel, Puebla, Pue. 72570, Mexico. Laboratorio Experimental de Enfermedades Neurodegenrativas, Instituto Nacional de Neurologia y Neurocirugia, Manuel Velasco Suarez, 14269 Mexico City, Mexico. Departamento de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia, Manuel Velasco Suarez, 14269 Mexico City, Mexico. Departamento de Bioquimica, Instituto Nacional de Enfermedades Respiratorias, Mexico, D.F., Mexico. Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico. Departamento de Quimica Organica, Facultad de Ciencias Quimicas, Benemerita, Universidad Autonoma de Puebla, Av. San Claudio y 14 Sur, Col. San Manuel, Puebla, Pue. 72570, Mexico. Lab. de Quimica Teorica, Centro de Investigacion, Dpto. de Fisicoquimica, Facultad de Ciencias Quimicas, Benemerita Universidad Autonoma de Puebla, Edif. 105-I, San Claudio y 22 Sur, Ciudad Universitaria, Col. San Manuel, Puebla, Puebla 72570, Mexico. Departamento de Farmacia, Facultad de Ciencias Quimicas Benemerita Universidad Autonoma de Puebla, Av. San Claudio y 14 Sur, Col. San Manuel, Puebla, Pue. 72570, Mexico. Electronic address: alfonso.diaz@correo.buap.mx. Departamento de Fisicomatematicas, Facultad de Ciencias Quimicas Benemerita Universidad Autonoma de Puebla, Av. San Claudio y 14 Sur, Col. San Manuel, Puebla, Pue. 72570, Mexico. Electronic address: ramses.ramirez@correo.buap.mx.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20160416",
     "PL": "Netherlands",
     "TA": "Neuropeptides",
     "JT": "Neuropeptides",
     "JID": "8103156",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Antioxidants)",
          "0 (Neuroprotective Agents)",
          "0 (Peptide Fragments)",
          "0 (Reactive Oxygen Species)",
          "0 (amyloid beta-protein (25-35))",
          "8R1V1STN48 (Catechin)"
     ],
     "SB": "IM",
     "MH": [
          "Amyloid beta-Peptides/*pharmacology",
          "Animals",
          "Antioxidants/*pharmacology",
          "Catechin/*pharmacology",
          "Cell Death/drug effects",
          "Hippocampus/*drug effects/metabolism",
          "Lipid Peroxidation/drug effects",
          "Male",
          "Neurons/drug effects/metabolism",
          "Neuroprotective Agents/pharmacology",
          "Oxidative Stress/*drug effects",
          "Peptide Fragments/*pharmacology",
          "Rats",
          "Rats, Wistar",
          "Reactive Oxygen Species/metabolism",
          "Static Electricity"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Amyloid- beta(25-35)",
          "Astrocytes",
          "Electrostatic potential",
          "Flavonoid compounds",
          "Hippocampus",
          "Oxidative stress"
     ],
     "EDAT": "2016/04/28 06:00",
     "MHDA": "2017/02/15 06:00",
     "CRDT": [
          "2016/04/28 06:00"
     ],
     "PHST": [
          "2015/12/03 00:00 [received]",
          "2016/04/12 00:00 [revised]",
          "2016/04/12 00:00 [accepted]",
          "2016/04/28 06:00 [pubmed]",
          "2017/02/15 06:00 [medline]",
          "2016/04/28 06:00 [entrez]"
     ],
     "AID": [
          "S0143-4179(16)30038-5 [pii]",
          "10.1016/j.npep.2016.04.001 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropeptides. 2016 Oct;59:89-95. doi: 10.1016/j.npep.2016.04.001. Epub 2016 Apr 16.",
     "term": "hippocampus"
}